First and Foremost Battle the Virus: Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment.


BACKGROUND There has been tremendous progress regarding treatment options for hepatitis C virus (HCV) infection. Several interferon-free regimens are awaiting regulatory approval. These innovations promise substantial reductions in the burden of disease and side effects as well as a decrease in treatment duration. OBJECTIVES The aim of this quantitaitive… (More)
DOI: 10.1016/j.jval.2016.04.007


  • Presentations referencing similar topics